Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Protalix BioTherapeutics, Inc. kasuwar kasuwa

Matsayin kasuwancin jari na Protalix BioTherapeutics, Inc. a yau da kuma tarihin ƙaddamar da Protalix BioTherapeutics, Inc. daga farkon kasuwanci a PLX hannun jari akan musayar jari.
Ƙara zuwa widget din
Ƙara zuwa widget din

Protalix BioTherapeutics, Inc. girma

Yau kasuwa kasuwa na Protalix BioTherapeutics, Inc. shine 185 914 448 US dollar.
+5 164 288 $ (+2.86%)
canji na strongn kudi tun jiya

Protalix BioTherapeutics, Inc. ikon mallaka a daloli a yau. Kowace rana, muna yin rikodin canji a cikin Protalix BioTherapeutics, Inc. ikon mallaka. Protalix BioTherapeutics, Inc. taken capitalization na yau akan rukunin yanar gizon mu don tunani. Protalix BioTherapeutics, Inc. kasuwar fila a yau ita ce $ 185 914 448.

Protalix BioTherapeutics, Inc. girma na kasuwanci

Yau yaudarar kasuwancin jari Protalix BioTherapeutics, Inc. ya kai 1 693 588 US dollar.
-3 716 112 $ (-68.69%)
canjin karuwar kasuwancin tun jiya

Protalix BioTherapeutics, Inc. Darajar ciniki a yau shine 1 693 588 dalar Amurka. Protalix BioTherapeutics, Inc. an gabatar da ginshiƙi mai ciniki a shafin yau da kullun. Protalix BioTherapeutics, Inc. Ana gudanar da kasuwancin kan layi akan kasuwannin hannayen jari da yawa, muna nuna jimlar Protalix BioTherapeutics, Inc. ciniki a kowace rana. Protalix BioTherapeutics, Inc. kasuwar tafiya ta yi kasa a jiya.

Nuna:
To

Protalix BioTherapeutics, Inc. kasuwar kasuwa

Protalix BioTherapeutics, Inc. aikin kwalliya akan zane a shekaru. Canjin Protalix BioTherapeutics, Inc. ikon mallaka a mako guda shine 20%. Protalix BioTherapeutics, Inc. canjin tsarin sarauta na shekara shine 0%. Protalix BioTherapeutics, Inc., ikon mallaka a yanzu - 185 914 448 dalar Amurka.

Week Watan 3 months Shekara 3 shekaru

Protalix BioTherapeutics, Inc. tarihin lalata

Kwanan Girma
Babban jari (kasuwannin kasuwa) shine kasuwa na kasuwa na kamfanonin da ke sayarwa akan musayar jari. Mahimmancin kasuwancin yana daidai da farashin hannun jari da yawa ta hanyar yawan kuɗi.
04/05/2023 185 914 448 $
03/05/2023 180 750 160 $
02/05/2023 155 789 408 $
01/05/2023 166 404 912 $
28/04/2023 158 945 376 $
27/04/2023 151 485 840 $
26/04/2023 154 928 704 $

Protalix BioTherapeutics, Inc. tashar girma

Week Watan 3 months Shekara 3 shekaru

Protalix BioTherapeutics, Inc. bayanan tarihi na tarihi

Kwanan Volume (24h)
Ƙaramar kasuwancin Protalix BioTherapeutics, Inc. hannun jari shine yawan yawan ma'amaloli tare da hannun jari na PLX da aka saya a lokacin da aka zaba.
04/05/2023 1 693 588 $
03/05/2023 5 409 700 $
02/05/2023 2 165 417 $
01/05/2023 2 739 510 $
28/04/2023 1 777 766 $
27/04/2023 1 007 339 $
26/04/2023 3 157 284 $

Protalix BioTherapeutics, Inc. ikon mallaka a dalar Amurka yanzu a 04/05/2023. Protalix BioTherapeutics, Inc. aikin mallaka a 03/05/2023 yayi daidai da 180 750 160 dalar Amurka. Protalix BioTherapeutics, Inc. karuwancin kasuwa a 02/05/2023 yayi daidai da 155 789 408 dalar Amurka. Protalix BioTherapeutics, Inc. karfaffen kaya ya kasance zuwa 166 404 912 Dalar Amurka a 01/05/2023.

A 28/04/2023, Protalix BioTherapeutics, Inc. taken kasuwa shine $ 158 945 376. Protalix BioTherapeutics, Inc. capitalization kasuwa shine $ 151 485 840 a 27/04/2023. A 26/04/2023, Protalix BioTherapeutics, Inc. taken kasuwa shine $ 154 928 704.

A capitalization na Protalix BioTherapeutics, Inc. a yau shi ne 185 914 448 $. Girman kasuwa na Protalix BioTherapeutics, Inc. ya canza zuwa +2.86% idan aka kwatanta da jiya. Hanyoyin ciniki na PLX hannun jari na Protalix BioTherapeutics, Inc. a rana ta ƙarshe ta kasuwanci ya kasance 1 693 588 $. Ƙarin ciniki na Protalix BioTherapeutics, Inc. ya canza zuwa -68.693% idan aka kwatanta da ranar ciniki.

Kudin hannun jari Protalix BioTherapeutics, Inc.

Finance Protalix BioTherapeutics, Inc.